Vanguard (HOLX) amendment shows 0 shares after Jan 12, 2026 realignment
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 12 to Schedule 13G/A reporting 0 shares of Hologic Inc Common Stock. The filing states that, following an internal realignment effective January 12, 2026, certain subsidiaries and business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The Vanguard Group confirms it holds 0 shares and 0% of the class, and that no single outside person is known to hold more than 5% of the securities reported. The form is signed by Ashley Grim, Head of Global Fund Administration.
Positive
- None.
Negative
- None.
FAQ
What does The Vanguard Group report for HOLX ownership?
The Vanguard Group reports 0 shares and 0% ownership of Hologic Inc common stock. The filing states subsidiaries now report ownership separately after an internal realignment dated January 12, 2026.
Does the filing show any party holds more than 5% of HOLX?
The filing states that no other person's interest reported herein exceeds 5%. It also notes shareholder listings for registered investment companies or plan beneficiaries are not required in this response.
Who signed the amendment and when was it signed?
The amendment is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/27/2026 on the filing.
What SEC release does Vanguard cite for disaggregated reporting?
The filing cites SEC Release No. 34-39538 (January 12, 1998), saying Vanguard relies on that release to allow subsidiaries or business divisions to report beneficial ownership separately following the realignment.